Skip to main content
BoomMag: Readers and Fans
Advertise With Us

WLT Report WLT Report

Advertise With Us
We may receive compensation from affiliate partners for some links on this site. Read our full Disclosure here.

Supreme Court Makes MAJOR Decision

The Supreme Court just dropped a bombshell.

On Thursday, they shot down a challenge to the FDA’s approval of the abortion drug mifepristone.

This is the latest chapter in the war to save babies since Roe v. Wade got axed in 2022.

The justices unanimously decided that the challengers didn’t even have the standing to sue the government.

Liberals now have cause to celebrate.

They can keep their abortion pill.

Will teachers start secretly handing these out?

The death cult that parades as ‘rights for women’ presses forward, ever determined to keep the body count rising.

ADVERTISEMENT

Fox News reports:

The Supreme Court on Thursday ruled against a challenge to the Food and Drug Administration’s (FDA) regulatory approval process of the abortion drug mifepristone, in the latest abortion case since the landmark decision in 2022 that overturned Roe v. Wade.

In a victory for the Biden administration and abortion rights supporters, the high court gave a unanimous decision that challengers to the FDA lacked standing to sue the government.

“Under Article III of the Constitution, a plaintiff’s desire to make a drug less available for others does not establish standing to sue. Nor do the plaintiffs’ other standing theories suffice,” Justice Brett Kavanaugh wrote, who authored the unanimous opinion.

“The plaintiffs have sincere legal, moral, ideological, and policy objections to elective abortion and to FDA’s relaxed regulation of mifepristone,” he said. “But under Article III of the Constitution, those kinds of objections alone do not establish a justiciable case or controversy in federal court.” The case was remanded back down to the Fifth Circuit consistent with the Court’s opinion.

The case stemmed from a set of lawsuits filed by a group of health care associations, Alliance for Hippocratic Medicine, who claimed that the drug has a high rate of complications.

Erin Hawley, counsel for the civil rights firm Alliance Defending Freedom, who argued the case against the FDA, said, “We are disappointed that the Supreme Court did not reach the merits of the FDA’s lawless removal of commonsense safety standards for abortion drugs. ”

“Nothing in today’s decision changes the fact that the FDA’s own label says that roughly one in 25 women who take chemical abortion drugs will end up in the emergency room — a dangerous reality the doctors and medical associations we represent in this case know all too well. The FDA recklessly leaves women and girls to take these high-risk drugs all alone in their homes or dorm, without requiring the ongoing, in-person care of a doctor,” she said.

“While we’re disappointed with the court’s decision, we will continue to advocate for women and work to restore commonsense safeguards for abortion drugs — like an initial office visit to screen for ectopic pregnancies. And we are grateful that three states stand ready to hold the FDA accountable for jeopardizing the health and safety of women and girls across this country,” she said.

The Supreme Court said that the group couldn’t prove that the FDA’s relaxed rules would have caused them injury, enough to give them standing to sue.

“Here, the plaintiffs have failed to demonstrate that FDA’s relaxed regulatory requirements likely would cause them to suffer an injury in fact. For that reason, the federal courts are the wrong forum for addressing the plaintiffs’ concerns about FDA’s actions,” Kavanaugh said.

“The plaintiffs may present their concerns and objections to the President and FDA in the regulatory process, or to Congress and the President in the legislative process. And they may also express their views about abortion and mifepristone to fellow citizens, including in the political and electoral processes,” he wrote.

In March, the justices heard about 90 minutes of arguments about federal government regulations since 2016 that made access to mifepristone easier, including access by mail.

In overturning Roe v. Wade in June 2022, the Supreme Court ruled in Dobbs v. Jackson Women’s Health Organization that the U.S. Constitution does not guarantee the right to an abortion and that the matter may be decided by the states.

In the aftermath, 14 states have banned abortion at all stages of pregnancy, with some exceptions, and two others have banned abortion once a fetal heartbeat is detected, which is at around six weeks of gestation.

Mifepristone is taken along with misoprostol, and the two-drug combination is known as medication abortion or the “abortion pill.”

Lower courts concluded the federal agency did not fully consider the potential health risks to women when revising regulations for mifepristone beginning in 2016. Those revisions — last updated in 2023 — include reducing the recommended dose, allowing use of the drug up to 10 weeks of pregnancy (from seven weeks), approving a generic version and permitting it to be mailed (eliminating in-person doctor visits), among other measures.

The Biden administration and the maker of mifepristone asked the Court to reverse an appellate ruling that would cut off access to the drug through the mail and impose other restrictions, even in states where abortion remains legal.

What do you think?

Still have faith in those sitting on the Supreme Court?


, , ,

 

Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

log in

Forgot password?

reset password

Back to
log in
Leave a comment
Thanks for sharing!
Thanks for sharing!
We invite you to become a WLT Report insider. Sign up for our free email newsletter, and we'll make sure to keep you in the loop.